Show simple item record

dc.contributor.authorPurohit, Maulik Prafull
dc.contributor.authorZafonte, Ross Dennis
dc.contributor.authorSherman, Laura M.
dc.contributor.authorDavis, Roger B.
dc.contributor.authorGiwerc, Michelle Y.
dc.contributor.authorShenton, Martha Elizabeth
dc.contributor.authorYeh, Gloria Y.
dc.date.accessioned2018-04-12T20:08:15Z
dc.date.issued2015
dc.identifier.citationPurohit, Maulik P., Ross D. Zafonte, Laura M. Sherman, Roger B. Davis, Michelle Y. Giwerc, Martha E. Shenton, and Gloria Y. Yeh. 2015. “Neuropsychiatric Symptoms and Expenditure on Complementary and Alternative Medicine.” The Journal of Clinical Psychiatry (July 22): e870–e876. doi:10.4088/jcp.13m08682.en_US
dc.identifier.issn0160-6689en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:35644991
dc.description.abstractObjective—Neuropsychiatric symptoms affect 37% of US adults. These symptoms are often refractory to standard therapies, and patients may consequently opt for complementary and alternative medicine therapies (CAM). We sought to determine the demand for CAM by those with neuropsychiatric symptoms compared to those without neuropsychiatric symptoms as measured by out-of-pocket expenditure. Method—We compared CAM expenditure between US adults with and without neuropsychiatric symptoms (n = 23,393) using the 2007 National Health Interview Survey. Symptoms included depression, anxiety, insomnia, attention deficits, headaches, excessive sleepiness, and memory loss. CAM was defined per guidelines from the National Institutes of Health as mind body therapies, biological therapies, manipulation therapies, or alternative medical systems. Expenditure on CAM by those without neuropsychiatric symptoms was compared to those with neuropsychiatric symptoms. Results—Of the adults surveyed, 37% had ≥ 1 neuropsychiatric symptom and spent $ 14.8 billion out-of-pocket on CAM. Those with ≥ 1 neuropsychiatric symptom were more likely than those without neuropsychiatric symptoms to spend on CAM (27.4% vs 20.3%, P < .001). Likelihood to spend on CAM increased with number of symptoms (27.2% with ≥ 3 symptoms, P < .001). After adjustment was made for confounders using logistic regression, those with ≥ 1en_US
dc.language.isoen_USen_US
dc.publisherPhysicians Postgraduate Press, Incen_US
dc.relation.isversionofdoi:10.4088/JCP.13m08682en_US
dc.relation.hasversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729567/en_US
dash.licenseOAP
dc.titleNeuropsychiatric Symptoms and Expenditure on Complementary and Alternative Medicineen_US
dc.typeJournal Articleen_US
dc.description.versionAccepted Manuscripten_US
dc.relation.journalJ. Clin. Psychiatryen_US
dash.depositing.authorShenton, Martha Elizabeth
dc.date.available2018-04-12T20:08:15Z
dc.identifier.doi10.4088/JCP.13m08682*
dash.identifier.orcid0000-0003-4235-7879en_US
dash.contributor.affiliatedZafonte, Ross
dash.contributor.affiliatedPurohit, Maulik Prafull
dash.contributor.affiliatedYeh, Gloria
dash.contributor.affiliatedDavis, Roger
dash.contributor.affiliatedShenton, Martha


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record